electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS

electroCore (NASDAQ:ECOR) posted its quarterly earnings data on Wednesday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.07), FiscalAI reports. The company had revenue of $8.69 million for the quarter, compared to analyst estimates of $7.84 million. electroCore had a negative return on equity of 221.93% and a negative net margin of 47.84%. electroCore updated its FY 2025 guidance to EPS.

electroCore Stock Up 23.5%

Shares of NASDAQ:ECOR traded up $1.12 during trading on Thursday, reaching $5.86. 377,505 shares of the company traded hands, compared to its average volume of 112,254. electroCore has a 52 week low of $4.16 and a 52 week high of $19.49. The firm has a market capitalization of $46.82 million, a PE ratio of -3.61 and a beta of 0.30. The company’s 50 day moving average is $5.01 and its two-hundred day moving average is $5.61.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Wall Street Zen cut electroCore from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of electroCore in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, electroCore presently has a consensus rating of “Hold” and an average price target of $25.50.

Insider Transactions at electroCore

In other news, Director Thomas J. Errico bought 15,000 shares of the stock in a transaction on Monday, August 11th. The stock was acquired at an average price of $4.47 per share, with a total value of $67,050.00. Following the acquisition, the director directly owned 281,401 shares in the company, valued at approximately $1,257,862.47. This trade represents a 5.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 13.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On electroCore

Institutional investors and hedge funds have recently made changes to their positions in the stock. NewEdge Advisors LLC grew its stake in electroCore by 857.9% during the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after purchasing an additional 145,047 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in electroCore in the first quarter worth $153,000. Finally, Jane Street Group LLC grew its position in shares of electroCore by 114.4% in the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after purchasing an additional 19,599 shares in the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.